Issue Date: September 24, 2012
Resurgence For Medical Polymers
Polymer suppliers haven’t forgotten the bitter lessons that can come with the use of their materials in medical devices. They know all too well Dow Corning’s nine years in bankruptcy, which ended in 2004, and the $3.2 billion the firm agreed to pay to women who claimed that silicone breast implants made them ill.
Today, however, polymer suppliers can count on the legal protections of the Biomaterials Access Assurance Act of 1998. And as new . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society